Hyper bilirubinemia. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: The first intervention group will receive 10 mg/kg of phenobarbital by injection in the quadriceps muscle and then 3 mg/kg orally in two doses every 12 hours. Intervention 2: The secon
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Days to 8 Days
Inclusion criteria
Inclusion criteria: Informed consent of the infant's parents Babies over 37 weeks old, 2-8 days old Primary bilirubin 15 to 25 mg/dL
Exclusion criteria
Exclusion criteria: History of phenobarbital use by the mother during pregnancy or use of phenobarbital for the baby for any reason, such as neonatal convulsions Presence of organomegaly adrenal hematoma and cephalhematoma History of phototherapy or previous blood exchange Blood dyscrasias
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood bilirubin level. Timepoint: upon arrival and 6, 12, 24, 36, 48 and 72 hours (if hospitalized for at least 36 hours) after the start of the study. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mazyar Vakili Amini
Kermanshah University of Medical Sciences
Outcome results
None listed